פלודקאט
unipharm trading ltd, israel - fluphenazine decanoate - תמיסה להזרקה - fluphenazine decanoate 25 mg/ml - fluphenazine - fluphenazine - management of psychotic disorders.
פריקאט
unipharm trading ltd, israel - haloperidol as decanoate - תמיסה להזרקה - haloperidol as decanoate 100 mg/ml - haloperidol - haloperidol - long term maintenance treatment of schizophrenia and mental or behaivoral problems.
פרבליפ 10
unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 10 mg - pravastatin
פירון 267
unipharm ltd, israel - pirfenidone - טבליה - pirfenidone 267 mg - pirfenidone
פירון 801
unipharm ltd, israel - pirfenidone - טבליה - pirfenidone 801 mg - pirfenidone
סילריל 2.5
unipharm ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.
סילריל 5
unipharm ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - a blood pressure lowering agent. chronic heart failure.
סילריל פלוס
unipharm ltd, israel - cilazapril; hydrochlorothiazide - טבליה - cilazapril 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.
סילריל 1
unipharm ltd, israel - cilazapril - טבליה - cilazapril 1 mg - cilazapril - cilazapril - a blood pressure lowering agent.chronic heart failure.
טורבה 10
unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 10 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/